Oncology management tools are evolving beyond traditional prior authorization toward more sophisticated approaches, including value-based pathways, reimbursement restructuring, and data-driven oversight. This paper reviews how these emerging controls are being deployed and how they are influencing treatment patterns, access, and stakeholder alignment across the oncology ecosystem.

Click here for a printable PDF